Results 331 to 340 of about 2,716,837 (401)
JAMA DermatolSome of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2022
• A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria.• Extended laboratory tests rarely yield clinically significant or actionable findings, and hence are not recommended.• Most patients experience symptomatic relief following treatment with H1 antihistamines, omalizumab, or cyclosporine, with eventual ...
Joanne I, Hsu, Sylvia, Hsu
semanticscholar +11 more sources
• A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria.• Extended laboratory tests rarely yield clinically significant or actionable findings, and hence are not recommended.• Most patients experience symptomatic relief following treatment with H1 antihistamines, omalizumab, or cyclosporine, with eventual ...
Joanne I, Hsu, Sylvia, Hsu
semanticscholar +11 more sources
Allergy. European Journal of Allergy and Clinical Immunology, 2022
Chronic inducible urticaria (CIndU) is characterized by mast cell (MC)‐mediated wheals in response to triggers: cold in cold urticaria (ColdU) and friction in symptomatic dermographism (SD).
D. Terhorst‐Molawi +11 more
semanticscholar +1 more source
Chronic inducible urticaria (CIndU) is characterized by mast cell (MC)‐mediated wheals in response to triggers: cold in cold urticaria (ColdU) and friction in symptomatic dermographism (SD).
D. Terhorst‐Molawi +11 more
semanticscholar +1 more source
Omalizumab for Chronic Urticaria
New England Journal of Medicine, 2013N ...
Karin Rosén +2 more
openaire +7 more sources
Journal of the American Academy of Dermatology, 2002
Chronic urticaria has a spectrum of clinical presentations and causes. About 50% of patients with "idiopathic" disease have histamine-releasing autoantibodies in their blood. The term autoimmune urticaria is increasingly being accepted for this subgroup of patients, in whom immunosuppressive therapies may be appropriate if conventional approaches to ...
Clive E H, Grattan +2 more
openaire +2 more sources
Chronic urticaria has a spectrum of clinical presentations and causes. About 50% of patients with "idiopathic" disease have histamine-releasing autoantibodies in their blood. The term autoimmune urticaria is increasingly being accepted for this subgroup of patients, in whom immunosuppressive therapies may be appropriate if conventional approaches to ...
Clive E H, Grattan +2 more
openaire +2 more sources
Journal of Allergy and Clinical Immunology, 1995
Chronic urticaria remains a major problem in terms of etiology, investigation, and management. It is important to identify patients in whom physical urticaria is the principal cause of disability. Once confirmed by appropriate challenge testing, no further investigation is required.
openaire +3 more sources
Chronic urticaria remains a major problem in terms of etiology, investigation, and management. It is important to identify patients in whom physical urticaria is the principal cause of disability. Once confirmed by appropriate challenge testing, no further investigation is required.
openaire +3 more sources
Treatment of Chronic Urticaria
Immunology and Allergy Clinics of North America, 2014Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs.
R. Asero, A. Tedeschi, M. Cugno
openaire +3 more sources